U.S.-based Pfizer Inc. says it has resolved U.S. Department of Justice and Securities and Exchange Commission matters related to certain improper payments in the operations of two of its subsidiaries outside the United States, which Pfizer voluntarily reported to the U.S. government beginning in 2004. To resolve those historical issues, a Pfizer indirect subsidiary named […]
↧